耐甲氧西林金黄色葡萄球菌(methicillin-resistant staphylococcus aureus,MRSA)作为超级细菌的典型代表,严重威胁人民群众的健康。目前经典的抗生素治疗和疫苗主动预防都无法有效控制MRSA的感染。近年来,随着抗体药物产业的兴起,诸多药物研发公司和研究人员致力于研究治疗性抗体,以期控制MRSA的感染并已经取得了很多突破。就治疗MRSA感染的抗体药物研究进展作一简要综述。 Methicillin-resistant staphylococcus aureus (MRSA) as a typical representative of super bacteria, a serious threat to the health of the people. The current classic antibiotic treatment and active vaccine prevention can not effectively control the infection of MRSA. In recent years, with the rise of the antibody and drug industry, many drug development companies and researchers are dedicated to researching therapeutic antibodies to control MRSA infections and many breakthroughs have been made. A brief review on the progress of research on antibody drugs for MRSA infection.